Top Tardive Dyskinesia Treatment Companies | Major Players 2026

Code: MTA14619 Publication Date: Oct 2026

Top Tardive Dyskinesia Treatment Companies 

The following is a data-backed list of the leading Tardive Dyskinesia Treatment Companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. Tanabe Pharma, Luye Pharma Group currently lead the competitive landscape, alongside several other established players shaping the Global Tardive Dyskinesia Treatment Market.

For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Global Tardive Dyskinesia Treatment Market.

List of Tardive Dyskinesia Treatment Companies:

1. Tanabe Pharma Corporation

Company NameTanabe Pharma Corporation
Established Year1678
HeadquartersOsaka, Japan
Official WebsiteClick Here

Tanabe Pharma, a subsidiary of Mitsubishi Chemical Group, develops specialty pharmaceuticals for central nervous system (CNS) disorders, autoimmune diseases, and neurodegenerative conditions globally.

2. Luye Pharma Group Ltd.

Company NameLuye Pharma Group Ltd.
Established Year1994
HeadquartersYantai, Shandong, China
Official WebsiteClick Here

Luye Pharma Group is an international pharmaceutical company focusing on central nervous system (CNS) disorders, oncology, and cardiovascular therapies, utilizing advanced drug delivery systems for long-acting injectable formulations.

3. Neurocrine Biosciences, Inc.

Company NameNeurocrine Biosciences, Inc.
Established Year1992
HeadquartersSan Diego, California, United States
Official WebsiteClick Here

Neurocrine Biosciences is a biopharmaceutical leader focused on neuroscience, renowned for developing valbenazine, a flagship selective vesicular monoamine transporter 2 (VMAT2) inhibitor approved for tardive dyskinesia.

4. SOM Biotech SL

Company NameSOM Biotech SL
Established Year2009
HeadquartersBarcelona, Catalonia, Spain
Official WebsiteClick Here

SOM Biotech is a clinical-stage biopharmaceutical company utilizing proprietary AI-based drug repurposing platforms to discover and develop treatments for orphan CNS diseases.

5. Acadia Pharmaceuticals Inc.

Company NameAcadia Pharmaceuticals Inc.
Established Year1993
HeadquartersSan Diego, California, United States
Official WebsiteClick Here

Acadia Pharmaceuticals specializes in developing and commercializing innovative therapies for central nervous system disorders, including treatments for Parkinson's disease psychosis and Rett syndrome, alongside ongoing R&D in neuropsychiatry.

6. AbbVie Inc.

Company NameAbbVie Inc.
Established Year2013
HeadquartersNorth Chicago, Illinois, United States
Official WebsiteClick Here

AbbVie is a global research-based biopharmaceutical enterprise with a comprehensive neuroscience portfolio, offering therapies for Parkinson's diseases and movement conditions following its acquisition of Allergan.

7. Serina Therapeutics, Inc.

Company NameSerina Therapeutics, Inc.
Established Year2006
HeadquartersHuntsville, Alabama, United States
Official WebsiteClick Here

Serina Therapeutics is a pharmaceutical development company advancing small-molecule therapeutics using its proprietary POZ polymer platform to target CNS conditions, including Parkinson's disease.

8. Teva Pharmaceutical Industries Ltd.

Company NameTeva Pharmaceutical Industries Ltd.
Established Year1901
HeadquartersTel Aviv, Israel
Official WebsiteClick Here

Teva Pharmaceutical Industries is a global leader in generic and specialty pharmaceuticals, widely recognized for developing deutetrabenazine, a modified VMAT2 inhibitor approved for tardive dyskinesia and Huntington's chorea.

9. Medicure Inc.

Company NameMedicure Inc.
Established Year1997
HeadquartersWinnipeg, Manitoba, Canada
Official WebsiteClick Here

Medicure is a specialty pharmaceutical company focused on the development, acquisition, and commercialization of cardiovascular and neurological therapeutic products for acute and chronic care markets.

10. Sun Pharmaceutical Industries Ltd.

Company NameSun Pharmaceutical Industries Ltd.
Established Year1983
HeadquartersMumbai, Maharashtra, India
Official WebsiteClick Here

Sun Pharma is India's largest pharmaceutical company and a major global generic manufacturer, producing a broad portfolio of central nervous system therapeutics, generic neurology medicines, and specialty formulations.

Frequently Asked Questions About the Market Study (FAQs):
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
ISO 9001:2015

ISO 9001:2015 CERTIFIED

Quality Management System for market research & advisory services

Cert. No. 3050261008135Q

6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All